Wegovy Price 2026: What You'll Actually Pay for This Weight Loss Medication

If you've been prescribed Wegovy or are considering it for weight loss, you're probably wondering what it will actually cost you in 2026. The short answer? Without insurance, you're looking at anywhere from $1,349 to $1,799 per month—a price that puts this highly effective medication out of reach for many people who could benefit from it.

But don't close this tab just yet. Understanding the full picture of Wegovy pricing, insurance coverage, and legitimate alternatives can help you find a path to affordable GLP-1 therapy that fits your budget.

What Is Wegovy and Why Is It So Expensive?

Wegovy is the brand name for semaglutide when prescribed specifically for weight management. Manufactured by Novo Nordisk, it's the same active ingredient found in Ozempic, though Wegovy is FDA-approved for chronic weight management while Ozempic is approved for type 2 diabetes.

The high price tag reflects several factors: the medication's development costs, patent protection that prevents generic competition until 2032, complex manufacturing processes, and simply what the pharmaceutical market will bear. Novo Nordisk has maintained premium pricing despite increased production capacity in 2025 and early 2026.

Wegovy List Price in 2026

As of early 2026, Novo Nordisk's list price for Wegovy ranges from approximately $1,349 to $1,799 per month depending on the pharmacy and your location. This represents a slight increase from 2025 prices, though the company has faced pressure from advocacy groups and lawmakers to reduce costs.

Keep in mind that the list price—sometimes called the wholesale acquisition cost or WAC—isn't necessarily what you'll pay. Your actual out-of-pocket cost depends on several factors including your insurance coverage, deductible status, and eligibility for savings programs.

Does Insurance Cover Wegovy in 2026?

Insurance coverage for Wegovy remains inconsistent and often frustrating to navigate. Here's what the landscape looks like in 2026.

Commercial Insurance Plans

Some private insurance plans now cover Wegovy, but many still exclude weight loss medications entirely or place them on high-tier formularies with substantial copays. When coverage exists, you might pay anywhere from $25 to $500+ per month depending on your plan's structure.

Most plans that do cover Wegovy require prior authorization, meaning your doctor must demonstrate medical necessity—typically a BMI of 30 or higher, or 27 or higher with at least one weight-related health condition like high blood pressure or type 2 diabetes.

Medicare and Medicaid

As of 2026, traditional Medicare Part D plans still cannot cover medications prescribed solely for weight loss due to federal law, though there's ongoing legislative discussion about changing this restriction. However, if you have a Medicare Advantage plan, some do offer coverage for Wegovy as an additional benefit.

Medicaid coverage varies dramatically by state. Some states have added GLP-1 medications for weight loss to their formularies, while others maintain exclusions. Check with your state's Medicaid program for specific information.

Wegovy Savings Programs and Patient Assistance

Novo Nordisk offers a savings card for commercially insured patients that can reduce copays to as low as $25 per month, but this program has eligibility restrictions and monthly caps. If your insurance doesn't cover Wegovy at all, the savings card typically won't help.

The company also maintains a patient assistance program for uninsured or underinsured individuals who meet income requirements, though approval isn't guaranteed and the application process can take several weeks.

Gender Differences in Wegovy Costs

While Wegovy's list price is the same regardless of gender, women may face different financial challenges accessing this medication. Studies show women are prescribed weight loss medications more frequently than men, yet women statistically earn less and are more likely to work part-time jobs with limited health benefits.

Additionally, some insurance plans have historically been more likely to approve GLP-1 medications for men with obesity-related conditions like sleep apnea or heart disease, while viewing weight management for women as cosmetic rather than medical—though this is slowly changing as evidence grows for the cardiovascular and metabolic benefits of these medications.

Affordable Alternatives to Brand-Name Wegovy

If Wegovy's price tag is beyond your budget even with insurance, you have options worth discussing with your healthcare provider.

Compounded Semaglutide

Compounded semaglutide contains the same active ingredient as Wegovy but is prepared by specialized pharmacies rather than pharmaceutical manufacturers. Because it's compounded, it's not subject to the same patent restrictions and costs significantly less—often $99 to $399 per month depending on the provider and dosage.

The FDA allows compounding of medications that are in shortage or when there's a medical need for customization. While Wegovy availability has improved, compounded options remain legally available and are prescribed by licensed physicians following the same clinical protocols.

Other GLP-1 Medications

Depending on your medical history, your doctor might consider alternatives like tirzepatide (the active ingredient in Mounjaro and Zepbound), which works on both GLP-1 and GIP receptors. Pricing is similarly high for brand-name versions, but compounded tirzepatide is also available at lower costs.

Some patients with type 2 diabetes or prediabetes may be prescribed Ozempic (semaglutide for diabetes), which sometimes has better insurance coverage, though using it primarily for weight loss would be off-label.

What to Consider Before Starting Wegovy

Price is obviously important, but it shouldn't be your only consideration. Wegovy requires a long-term commitment—most people need to continue the medication to maintain weight loss. Calculate not just what you'll pay this month, but what you can sustainably afford over the next year or longer.

Also factor in the cost of medical monitoring. Responsible GLP-1 therapy includes regular check-ins with a healthcare provider to monitor side effects, adjust dosing, and ensure the medication is working safely and effectively.

From the Ozari Care Team

When patients ask us about affording GLP-1 therapy, we remind them that the most expensive medication is the one you can't take consistently. If budget constraints mean you'll skip doses or discontinue treatment prematurely, it's worth exploring compounded options from the start. The clinical outcomes with properly formulated compounded semaglutide mirror those of brand-name Wegovy when combined with appropriate medical supervision and lifestyle modification.

Finding Your Path to Affordable GLP-1 Therapy

Wegovy's 2026 pricing remains a significant barrier for many people who could benefit from this effective weight management tool. While insurance coverage is expanding and patient assistance programs exist, navigating these options can be complex and time-consuming.

The good news is that affordable alternatives like compounded semaglutide and tirzepatide make GLP-1 therapy accessible to more people. The key is working with a healthcare provider who understands both the clinical and financial aspects of weight management and can help you find a sustainable solution.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026